Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

XTL Biopharmaceuticals

0.8767
-0.0126-1.42%
Volume:25.12K
Turnover:22.37K
Market Cap:8.30M
PE:-0.73
High:0.9110
Open:0.9110
Low:0.8328
Close:0.8893
52wk High:2.57
52wk Low:0.5301
Shares:9.46M
Float Shares:5.17M
Volume Ratio:0.43
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1996
EPS(LYR):-0.1525
ROE:-577.13%
ROA:-240.56%
PB:-176.50
PE(LYR):-5.75

Loading ...

OverviewCompanyNewsFilings

XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency

TIPRANKS
·
Jan 28

XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure

TIPRANKS
·
Jan 24

XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance

TIPRANKS
·
Jan 24

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

GlobeNewswire
·
Jan 24

ADRs Hold Steady; XTL Biopharmaceuticals Ltd. Climbs 57%

Dow Jones
·
Jan 14

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:49 AM

Reuters
·
Jan 13

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire
·
Jan 13

XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement

TIPRANKS
·
Jan 13

ADRs Close Lower; XTL Biopharmaceuticals Ltd. Declines 16%

Dow Jones
·
Oct 10, 2025

Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?

TIPRANKS
·
Oct 08, 2025

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Aug 24, 2021
Financial Report Announcement
May 19, 2021
Financial Report Announcement
Mar 15, 2021
Financial Report Announcement
Aug 24, 2020
Financial Report Announcement
May 27, 2020

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.74
Current
-9.18
Sector Average
79.14%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.74
Maximum
28.55
+1 STD
11.71
Minimum
-90.45
-1 STD
-30.06
Average
-9.18

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.